Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice
Sarah R. Leist, Kenneth H. Dinnon, Alexandra Schäfer, et al.
Cell (2020) Vol. 183, Iss. 4, pp. 1070-1085.e12
Open Access | Times Cited: 600

Showing 1-25 of 600 citing articles:

An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19
Dafydd R. Owen, Charlotte Allerton, Annaliesa S. Anderson, et al.
Science (2021) Vol. 374, Iss. 6575, pp. 1586-1593
Open Access | Times Cited: 1546
Mechanisms of SARS-CoV-2 Transmission and Pathogenesis
Andrew G. Harrison, Lin Tao, Penghua Wang
Trends in Immunology (2020) Vol. 41, Iss. 12, pp. 1100-1115
Open Access | Times Cited: 1119
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Elisabetta Cameroni, John E. Bowen, Laura E. Rosen, et al.
Nature (2021) Vol. 602, Iss. 7898, pp. 664-670
Open Access | Times Cited: 1115
SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo
Yixuan J. Hou, S. Chiba, Peter Halfmann, et al.
Science (2020) Vol. 370, Iss. 6523, pp. 1464-1468
Open Access | Times Cited: 960
SARS-CoV-2 pathogenesis
Mart M. Lamers, Bart L. Haagmans
Nature Reviews Microbiology (2022) Vol. 20, Iss. 5, pp. 270-284
Open Access | Times Cited: 712
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
Peter Halfmann, Shun Iida, Kiyoko Iwatsuki‐Horimoto, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 687-692
Open Access | Times Cited: 599
Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement
Matthew McCallum, Nadine Czudnochowski, Laura E. Rosen, et al.
Science (2022) Vol. 375, Iss. 6583, pp. 864-868
Open Access | Times Cited: 510
The origins of SARS-CoV-2: A critical review
Edward C. Holmes, Stephen A. Goldstein, Angela L. Rasmussen, et al.
Cell (2021) Vol. 184, Iss. 19, pp. 4848-4856
Open Access | Times Cited: 452
Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice
Alexander A. Cohen, Priyanthi N.P. Gnanapragasam, Yu E. Lee, et al.
Science (2021) Vol. 371, Iss. 6530, pp. 735-741
Open Access | Times Cited: 390
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
Emma S. Winkler, Pavlo Gilchuk, Jinsheng Yu, et al.
Cell (2021) Vol. 184, Iss. 7, pp. 1804-1820.e16
Open Access | Times Cited: 354
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody
C. Garrett Rappazzo, Longping V. Tse, Chengzi I. Kaku, et al.
Science (2021) Vol. 371, Iss. 6531, pp. 823-829
Open Access | Times Cited: 352
The variant gambit: COVID-19’s next move
Jessica A. Plante, Brooke Mitchell, Kenneth S. Plante, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 4, pp. 508-515
Open Access | Times Cited: 347
COVID-19 vaccine development: milestones, lessons and prospects
Maochen Li, Han Wang, Lili Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 342
Human genetic and immunological determinants of critical COVID-19 pneumonia
Qian Zhang, Paul Bastard, Adem Karbuz, et al.
Nature (2022) Vol. 603, Iss. 7902, pp. 587-598
Open Access | Times Cited: 323
Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract
Tim Flerlage, David F. Boyd, Victoria Meliopoulos, et al.
Nature Reviews Microbiology (2021) Vol. 19, Iss. 7, pp. 425-441
Open Access | Times Cited: 312
SARS-CoV-2, COVID-19 and the aging immune system
Juliet M. Bartleson, Dina Radenković, Anthony J. Covarrubias, et al.
Nature Aging (2021) Vol. 1, Iss. 9, pp. 769-782
Open Access | Times Cited: 289
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
Dapeng Li, Robert J. Edwards, Kartik Manne, et al.
Cell (2021) Vol. 184, Iss. 16, pp. 4203-4219.e32
Open Access | Times Cited: 282
Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2
Sam Afkhami, Michael R. D’Agostino, Ali Zhang, et al.
Cell (2022) Vol. 185, Iss. 5, pp. 896-915.e19
Open Access | Times Cited: 272
Evidence for a mouse origin of the SARS-CoV-2 Omicron variant
Changshuo Wei, Ke-Jia Shan, Wei‐Guang Wang, et al.
Journal of genetics and genomics/Journal of Genetics and Genomics (2021) Vol. 48, Iss. 12, pp. 1111-1121
Open Access | Times Cited: 271
Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes
William N. Voss, Yixuan J. Hou, Nicole V. Johnson, et al.
Science (2021) Vol. 372, Iss. 6546, pp. 1108-1112
Open Access | Times Cited: 270
Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19
Shea A. Lowery, Alan Sariol, Stanley Perlman
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1052-1062
Open Access | Times Cited: 263
Understanding COVID-19-associated coagulopathy
Edward M. Conway, Nigel Mackman, Ronald Q. Warren, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 10, pp. 639-649
Open Access | Times Cited: 260
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
Ryuta Uraki, Maki Kiso, Shun Iida, et al.
Nature (2022) Vol. 607, Iss. 7917, pp. 119-127
Open Access | Times Cited: 255
Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy
Irfan Ullah, Jérémie Prévost, Mark S. Ladinsky, et al.
Immunity (2021) Vol. 54, Iss. 9, pp. 2143-2158.e15
Open Access | Times Cited: 199
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
David R. Martinez, Alexandra Schäfer, Sarah R. Leist, et al.
Science (2021) Vol. 373, Iss. 6558, pp. 991-998
Open Access | Times Cited: 180
Page 1 - Next Page

Scroll to top